Sadick Research Group
911 Park Avenue
New York, New York 10075
212-710-9855 http://www.sadickdermatology.com ekiang@sadickdermatology.com

Use our guide to learn which trials are right for you!

The Sadick Research Group was founded by Dr. Neil Sadick in 1993. Since its inception, the Sadick Research Group has built a reputation as one of the world's leading research centers for Medical and Cosmetic Dermatology and Cosmetic Surgical procedures and treatments.

Our research experience covers many areas of dermatology and includes the testing of safety and efficacy for new and innovative treatments. We have extensive experience working with innovative lasers and light sources as well as other innovative technologies including Cellulite and Non-surgical Fat Removal devices/treatments as well as At Home Devices. Our experience also covers treatments for ACNE, PSORIASIS, HAIR LOSS, FILLERS, INJECTABLES, BOTOX and various procedures for leg veins and hair transplantation.

The Sadick Research Group has been involved in numerous studies designed for FDA approval of new treatments or devices. In many cases, Dr. Sadick travels to the FDA to assist in the approval process. We have also invited the FDA to visit our facility and have received stellar results on our FDA audits.

The Sadick Research Group runs approximately 15 studies per year. By conducting a select number of studies per year, we offer our clients exceptional customer service and encourage regular communication with our sponsors to ensure clinical superiority. Dr. Sadick authors many articles for publication in prestigious peer-reviewed journals each year based on his research and clinical experience. Dr. Sadick is also well known for writing books and chapters on the most advanced Dermatologic treatments available today. He regularly lectures around the world at Dermatology and Cosmetic conferences and has been invited by the world's top educational facilities to train and teach physicians and medical students.

Dr. Sadick has contributed to the development of products and technologies that have significantly altered the medical landscape. These products and technologies include the following: intense pulsed light photo rejuvenation devices, lasers for the treatment of leg veins, lasers for hair removal, new energy technologies for skin tightening, new procedures for non-surgical fat removal, new treatments for cellulite and treatments for hair loss.

Dr. Sadick oversees every aspect of the Sadick Research Group which conducts all phases, early testing to pre-market approval, of clinical trials for new and innovative dermatologic procedures, treatments and technologies. The Sadick Research Group has been involved in clinical research for leading dermatology and aesthetics companies for more than 10 years.

Clients include: 3M, Allergan, Dermik, Diomed, Dusa, ICN/Cool Touch, Johnson & Johnson and Jobst-Beiersdorf, Laserscope, Lumenis, Radiancy, Reliant, Zeno Tyrell, Merck, and Syneron.

The Sadick Research Group has administered over seventy-five different research studies since its inception. Studies include:

  • Light treatment for acne
  • Cream treatment for hyperkeratosis
  • Cream treatment for photodamage and wrinkles
  • Light treatment for photodamage and wrinkles
  • Hair removal treatments
  • Propecia (Hair loss drug for men produced by Merck)
  • Lamisil (Anti-fungal antibiotic produced by Novartis)
  • New instrumentation for micro/minigraft hair transplantation
  • Laser hair transplantation
  • Lasers for leg veins
  • Lasers for hair removal including
  • Cosmetic utilization of fat and Fascian in anti-aging and contour form correction
  • New indications for microdermabrasion
  • The role of hormones in aging skin
  • New type of anesthetic for dermatologic surgery
  • New treatments for acne scarring
  • Intense Pulsed Light Photorejuvenation
  • ELOS Technology for rejuvenation and wrinkle reduction
  • Topical numbing agents

Dr. Neil Sadick, M.D., F.A.C.P., F.A.A.C.S., F.A.C.Ph, F.A.A.D is considered one of the world's leading dermatologists. He is an acknowledged innovator in the war against aging and a pioneer in aesthetic surgery and the science of beauty.

President of the American Academy of Cosmetic Surgery Foundation and a Clinical Professor of Dermatology at Weill Medical College of Cornell University, Dr. Sadick was also recently named as the Global Advisor to Christian Dior, where he will assist the company in developing breakthrough products.

A physician with experience in multiple specialties including Internal Medicine, Cosmetic Surgery, Dermatology, Phlebology and Hair Transplant Surgery, Dr. Sadick is considered one of the most significant contributors to the field of dermatology in the past ten years and his seminal research has been documented in hundreds of scientific articles, books and papers.

Dr. Sadick's achievements and educational contributions to science have been acknowledged through numerous prestigious awards, including the American Cancer Society Research Award, the Jobst Award for Research in Vascular Diseases, the AMA Continuing Education Award, and the New York Academy of Medicine Resident's Award. He has also been hailed as a "Best Doctor in New York" numerous times by New York Magazine and Castle Connolly's prestigious Peer Review Survey.

Located in Manhattan in New York City, our patients are of all racial and cultural backgrounds.


Dermatology/Plastic Surgery

Sadick Research Group is located in a new and expanded facility on Park Avenue in New York City, conveniently located near numerous forms of transportation.

Our research facility is state of the art and has a locked medication refrigerator / freezer (0ºC), locked cabinets for drug and record storage, an ultrasound device as well as a skin cooling device. Our facility includes the most advanced equipment for facial rejuvenation, vascular lesions, skin tightening, tattoo removal, hair removal, cellulite treatment and much more. We have access to the following facilities:

  • Certified Labs
  • Central IRB

Patient recruitment is achieved by accessing the following:

  • Growing Research Database
  • Large Patient Database
  • Advertising in Newspapers and Website Listings
  • Outreach to Colleagues in Relevant Specialties

Sadick Research Group
911 Park Avenue
New York, NY 10021
USA
212-710-9855 or 212-710-9849
212-517-9566 (fax)
ekiang@sadickdermatology.com
www.sadickdermatology.com


We've found
13 trials
at this facility
Psoriasis Clinical Trial
Study of the Efficacy and Safety Of Apremilast (CC-10004), in Subjects With Moderate Plaque Psoriasis
Status: Enrolling, Phase IV
Updated: 11/17/2015
mi
from
New York, NY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 11/23/2015
mi
from
New York, NY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
Status: Enrolling
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Acne Scars Clinical Trial
Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring
Status: Enrolling
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Psoriasis Clinical Trial
This Study is Being Conducted to Evaluate the Safety, Tolerability, and Efficacy of KD025 Administered Orally for 16 Weeks to Subjects With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy.
Status: Enrolling, Phase II
Updated: 3/6/2017
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Psoriasis Clinical Trial
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Dermatitis, Atopic Clinical Trial
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Assess the Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis
Status: Enrolling, Phase III
Updated: 11/25/2015
mi
from
New York, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Tradipitant in Treatment-Resistant Pruritus Associated With Atopic Dermatitis
Status: Upcoming, Phase II
Updated: 2/2/2016
mi
from
New York, NY
Click here to add this to my saved trials